abnormal bone marrow cell morphology/development_Ctsg<tm3.1(PML/RARA)Ley>/Ctsg<+>

http://metadb.riken.jp/0002398I129C57BL6Ctsgtm31PMLRARALeyCtsgCtsgtm31PMLRARALeyCtsg

abnormal bone marrow cell morphology/development_Ctsg<tm3.1(PML/RARA)Ley>/Ctsg<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• cathepsin G
  http://metadb.riken.jp/db/mgi_rdf/MGI:88563

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Ctsg<tm3.1(PML/RARA)Ley>/Ctsg<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Ctsg<tm3.1(PML/RARA)Ley>|Ctsg<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129 * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal bone marrow cell morphology/development
  http://purl.obolibrary.org/obo/MP_0002398

文献

http://purl.org/net/cito/citesAsAuthority

• Geoffrey L. Uy, et.al., A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of acute promyelocytic leukemia., Blood, 2010, 116
  http://rdf.ncbi.nlm.nih.gov/pubmed/20647568